|
Write about International Prognostic Index for the aggressive non-Hodgkin's lymphomas here.
International Prognostic Index for the aggressive non-Hodgkin's lymphomas
|
International Prognostic Index
|
|
Age >60
|
|
Serum lactate dehydrogenase concentration above normal
|
|
ECOG performance status 2
|
|
Ann Arbor stage III or IV
|
|
Number of extranodal disease sites >1
|
|
One point is given for each of the above characteristics present in the patient, for a total score ranging from zero to five. When applied to the initial group of 2031 patients with aggressive NHL, five-year overall survival (OS) and complete response (CR) rates according to score were as follows:
|
|
Score
|
Risk group
|
5-yr OS, percent
|
CR rate, percent
|
|
0 to 1
|
Low risk
|
73
|
87
|
|
2
|
Low-intermediate risk
|
51
|
67
|
|
3
|
High-intermediate risk
|
43
|
55
|
|
4 to 5
|
High risk
|
26
|
44
|
|
Age adjusted International Prognostic Index
|
|
For this score, all of the prognostic factors listed above, with the exception of age and number of extranodal sites, are given one point, for a score ranging from zero to three. When applied to the group of 761 patients >60 years of age, five-year OS and CR rates according to the adjusted score were as follows:
|
|
Score
|
Risk Group
|
5-yr OS, percent
|
CR rate, percent
|
|
0
|
Low risk
|
56
|
91
|
|
1
|
Low-intermediate risk
|
44
|
71
|
|
2
|
High-intermediate risk
|
37
|
56
|
|
3
|
High risk
|
21
|
36
|
|